36 | Levodopa (L Dopa)FDA LinkGeneric
01/2021
-
07/2004 |
20 | 1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
01/2019
-
06/2006 |
10 | Dopamine (Intropin)FDA LinkGeneric
01/2021
-
06/2010 |
3 | Amantadine (Aman)FDA LinkGeneric
11/2018
-
11/2006 |
3 | alpha-SynucleinIBA
01/2016
-
10/2010 |
3 | 5-HT1A Serotonin ReceptorIBA
10/2015
-
01/2012 |
3 | Pharmaceutical PreparationsIBA
08/2015
-
11/2005 |
3 | Dopamine Agents (Dopaminergic Agents)IBA
10/2013
-
09/2008 |
2 | oxidized low density lipoproteinIBA
01/2018
-
03/2013 |
2 | Serotonin (5 Hydroxytryptamine)IBA
10/2015
-
07/2014 |
2 | 3- ((4- (4- chlorophenyl)piperazin- 1- yl)methyl)- 1H- pyrrolo(2,3- b)pyridineIBA
02/2015
-
08/2012 |
2 | N- methyl- 1- cyclopropyl- 1- piperonylmethylamineIBA
07/2014
-
01/2012 |
2 | N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA
05/2012
-
05/2011 |
2 | N- (2- (4- (2- methoxyphenyl)- 1- piperazinyl)ethyl)- N- (2- pyridinyl)cyclohexanecarboxamideIBA
05/2012
-
01/2012 |
2 | Quetiapine Fumarate (Seroquel)FDA Link
05/2012
-
11/2006 |
2 | Clozapine (Clozaril)FDA LinkGeneric
05/2012
-
11/2006 |
2 | Antipsychotic Agents (Antipsychotics)IBA
05/2012
-
11/2006 |
2 | Oxidopamine (6 Hydroxydopamine)IBA
01/2011
-
04/2008 |
2 | Haloperidol (Haldol)FDA LinkGeneric
09/2008
-
11/2006 |
2 | Neuroprotective AgentsIBA
01/2006
-
07/2004 |
1 | Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA
01/2021 |
1 | DisaccharidesIBA
01/2019 |
1 | pridopidineIBA
01/2019 |
1 | TrehaloseIBA
01/2019 |
1 | Capsules (Microcapsules)IBA
11/2018 |
1 | N-Methylaspartate (NMDA)IBA
11/2018 |
1 | DPI-289IBA
01/2018 |
1 | Opioid Analgesics (Opioids)IBA
01/2018 |
1 | Narcotic Antagonists (Opioid Antagonists)IBA
01/2018 |
1 | 3- chloro- 4- fluorophenyl- (4- fluoro- 4- (((5- methylpyrimidin- 2- ylmethyl)amino)methyl)piperidin- 1- yl)methanoneIBA
10/2015 |
1 | Biomarkers (Surrogate Marker)IBA
08/2015 |
1 | PPAR gammaIBA
03/2015 |
1 | Peroxisome Proliferator-Activated Receptors (PPAR)IBA
03/2015 |
1 | Pioglitazone (Actos)FDA Link
03/2015 |
1 | Dopamine D4 Receptors (Dopamine D4 Receptor)IBA
02/2015 |
1 | Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
10/2013 |
1 | TC-8831IBA
10/2013 |
1 | Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA
03/2013 |
1 | entacapone (Comtan)FDA Link
03/2013 |
1 | N- (6- (2- aminophenylamino)- 6- oxohexyl)- 4- methylbenzamideIBA
02/2013 |
1 | Histone Deacetylase InhibitorsIBA
02/2013 |
1 | Adenosine Triphosphatases (ATPase)IBA
01/2013 |
1 | Neurotransmitter Agents (Neurotransmitter)IBA
01/2013 |
1 | Illicit Drugs (Recreational Drugs)IBA
05/2012 |
1 | 1- (2- methoxyphenyl)- 4- (4- (2- phthalimido)butyl)piperazineIBA
05/2012 |
1 | 5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA
01/2012 |
1 | KetanserinIBA
01/2012 |
1 | Naltrexone (ReVia)FDA LinkGeneric
06/2011 |
1 | mu Opioid Receptors (mu Opioid Receptor)IBA
06/2011 |
1 | Dihydroxyphenylalanine (Dopa)IBA
06/2011 |
1 | Dihydrotachysterol (AT 10)IBA
06/2011 |
1 | cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA
02/2011 |
1 | fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA
02/2011 |
1 | Proteins (Proteins, Gene)FDA Link
10/2010 |
1 | Histamine (Histamine Dihydrochloride)FDA Link
07/2010 |
1 | Famotidine (Pepcid)FDA LinkGeneric
07/2010 |
1 | Metabotropic Glutamate 5 ReceptorIBA
06/2010 |
1 | pyridineIBA
06/2010 |
1 | NociceptinIBA
10/2008 |
1 | J 113397IBA
10/2008 |
1 | Adenosine (Adenocard)FDA LinkGeneric
09/2008 |
1 | 1-aminocyclopentane-1,3,4-tricarboxylic acidIBA
09/2008 |
1 | Adenosine A2 Receptor AntagonistsIBA
09/2008 |
1 | Glutamic Acid (Glutamate)FDA Link
09/2008 |
1 | sarsasapogeninIBA
07/2008 |
1 | Nerve Growth Factors (Neurotrophins)IBA
07/2008 |
1 | G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
04/2008 |
1 | Receptor Activity-Modifying Protein 1IBA
04/2008 |
1 | ApomorphineFDA Link
11/2006 |
1 | Dopamine Agonists (Dopamine Agonist)IBA
09/2006 |
1 | imetitIBA
06/2006 |
1 | Histamine AgonistsIBA
06/2006 |
1 | 4-(1H-imidazol-4-ylmethyl)piperidineIBA
06/2006 |
1 | Histamine H3 Receptors (Histamine H3 Receptor)IBA
06/2006 |